Benicar Approved for Kids With High Blood Pressure

View the High Blood Pressure (Hypertension) Slideshow Pictures

THURSDAY, Feb. 11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16, drug maker Daiichi Sankyo said Thursday.

Some 3.6 million children in the United States have high blood pressure, a number that's risen in tandem with children's weight, the company said in a news release. Obese children are three times more likely to have hypertension than non-obese kids, the firm added.

Benicar blocks the actions of a hormone called angiotensin II to increase blood pressure.

Adverse reactions reported among children taking Benicar were similar to those of adults, including dizziness, Daiichi said.

-- Scott Roberts

Copyright © 2010 HealthDay. All rights reserved.

Subscribe to MedicineNet's Heart Health Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors